Etoricoxib

CAS 202409-33-4 4 current recordsSmall Molecule

Who holds supplier records for Etoricoxib? 4 organisations hold a current record for Etoricoxib: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (4).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Etoricoxib: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/etoricoxib

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    4 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Etoricoxib. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Etoricoxib sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Etoricoxib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL416146).

Chemical identity

IUPAC name
5-chloro-2-(6-methyl-3-pyridinyl)-3-(4-methylsulfonylphenyl)pyridine
Canonical SMILES
CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C
InChIKey
MNJVRJDLRVPLFE-UHFFFAOYSA-N
Synonyms
Arcoxia, Etoricoxib, L-791456, MK-0663, etoricoxibum, MK0663, L791456, CHEBI:6339, RefChem:388965, L 791456, M01AH05, Tauxib

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Etoricoxib?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Etoricoxib: METROCHEM API PRIVATE LTD (India), Alembic Pharmaceuticals Limited (India), Hetero Labs Limited (India) and SS PHARMA LLC (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Etoricoxib Drug Master Files are active?

METROCHEM API PRIVATE LTD (DMF 41843, 34537), Alembic Pharmaceuticals Limited (DMF 29951), Hetero Labs Limited (DMF 26044) and SS PHARMA LLC (DMF 43998). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Etoricoxib supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Etoricoxib?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.